Security key
293602108
- Security type / class
- Equity / COM
- Total 13F shares
- 3,155,042
- Total 13F value
- $9,559,000
- Share change
- +3,155,042
- SEC-reported price per share
- $3.03
- Number of holders
- 15
- Value change
- +$9,559,000
- Number of buys
- 15
Report period
Q3 2021
Institutions
15
Top holders
10
ENSC full security history
Ownership snapshot
Full 13F holder table
Ensysce Biosciences, Inc. SEC filings
Ensysce Biosciences, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ENSC - ENSYSCE BIOSCIENCES INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
A. Lorne Weil
Disclosed value leader
A. Lorne Weil
Comparable rows
0/6
Latest evidence
30 Jun 2021
3/4/5
Highest disclosed value: $1,868,005
6 rows are not safely comparable across share classes.
Quick read
A. Lorne Weil has the largest disclosed position value at $1.87M.
0 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens A. Lorne Weil's linked filing trail.
Disclosed position value
Top 4
A. Lorne Weil
$1.87M
Daniel B. Silvers
$1.75M
Eric Carrera
$30K
George Peng
$15K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 6 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| A. Lorne Weil |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$1,868,005
1,868,005 shares
|
— | 30 Jun 2021 |
| Daniel B. Silvers |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$1,754,497
1,754,497 shares
|
— | 30 Jun 2021 |
| Eric Carrera |
3/4/5
Former officer
|
—
denominator unverified
|
$30,000
30,000 shares
|
— | 30 Jun 2021 |
| George Peng |
3/4/5
Former officer
|
—
denominator unverified
|
$15,000
15,000 shares
|
— | 30 Jun 2021 |
| Richard Chester Wright |
3/4/5
Chief Business Officer
|
—
denominator unverified
|
—
987,750 shares
|
— | 30 Jun 2021 |
| William K. Schmidt |
3/4/5
Chief Medical Officer
|
—
denominator unverified
|
—
69,142 shares
|
— | 30 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
15
Shares
3,155,042
Rows available
15
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
0
Q3 2021 holders
15
Holder diff
15
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 value | Q3 2021 value | Value change | Value Chg % |
|---|